ESC 365 - Stepwise approach to lipid-lowering therapies: which one, when, and for whom?

ESC2025 Premium Access

Stepwise approach to lipid-lowering therapies: which one, when, and for whom?

Session: Challenges in the implementation of therapies for long-term management in coronary artery disease

Topic: Acute Coronary Syndromes

Speaker: Doctor M. O'Donoghue (Boston, US)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Doctor Michelle O'Donoghue

Brigham and Women's Hospital, Boston (United States of America)

9 presentations

6 followers

4 more presentations in this session

The cardiovascular polypill: simplicity to tackle a complex problem

Speaker: Professor F. Pinto (Lisbon, PT)

Colchicine: do we need more evidence?

Speaker: Doctor J. Tardif (Montreal, CA)

Challenges in the implementation of therapies for long-term management in coronary artery disease - patient perspective

Speaker: Mrs X. Pitsilli Kyriacou (Nicosia, CY)

Challenges in the implementation of therapies for long-term management in coronary artery disease - discussion

Access the full session

Challenges in the implementation of therapies for long-term management in coronary artery disease

Speakers: Doctor M. O'Donoghue, Professor F. Pinto, Doctor J. Tardif, Mrs X. Pitsilli Kyriacou

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources